The faculty at the Blavatnik Institute at Harvard Medical School are focused on solving human health challenges through fundamental and translational biomedical research.
VoLo Foundation’s grant to Harvard University for Harvard Medical School is a 3-year partnership aimed at establishing the current-use VoLo Research Fund on Aging. This fund specifically supports the work of David A. Sinclair, PhD., Professor of Genetics at the Blavatnik Institute at Harvard Medical School and co-director of the Paul F. Glenn Center for Biology of Aging Research. The primary purpose of the grant is to fund studies focused on understanding how to accurately measure the pace of aging in humans and what aging clocks represent in terms of future health through animal model studies.
Click here to read an article highlighting VoLo Foundation’s partnership with Harvard Medical School on page 10.
